TNF Alpha In Inflammation
TNF Alpha In Inflammation
批准号:
7219443
负责人:
KATHLEEN E SULLIVAN
金额:
$32.29万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-02-01 至 2009-03-31
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Over-expression of TNF alpha is almost always deleterious. Over-expression in mice is associated with both systemic autoimmunity and organ-specific inflammatory changes. Over-expression is seen in humans with a wide range of inflammatory disorders. To prevent the deleterious consequences of over-expression, TNF alpha appears to use both transcriptional silencing and translational silencing. The hypothesis addressed in the current proposal is that transcriptional repression of TNF alpha is mediated through a combination of DNA methylation, histone deacetylation and nuclear localization effects. In monocytes, these transcriptional repression strategies are hypothesized to be regulated by maturational stimuli. Our preliminary data demonstrates that progressive histone acetylation accompanies monocyte differentiation and that enforced histone acetylation can allow a non-expressing cell to express TNF alpha. These data strongly suggest that histone acetylation plays an important role in establishing transcriptional competency as monocytes mature. It is unknown at this time whether histone acetylation affects DNA methylation or vice versa. This proposal will address the hypothesis that DNA methylation, histone acetylation, and location with euchromatin are variables, which are regulated independently and govern the competence of the TNF alpha locus for transcription. To define the roles of these three variables, we will first analyze factors that govern the nuclear localization of the TNF alpha locus. Maturation, stimulation, and manipulation of DNA methylation and histone acetylation will be evaluated as variables regulating nuclear localization. The role of DNA methylation in the regulation of TNF alpha expression will be examined in the second aim. Bisulfite analysis will be used to define methylation patterns in monocytes at different maturational stages and the relationship between DNA methylation and histone acetylation examined using specific inhibitors. In the third aim, chromatin immunoprecipitation assays will be used to identify the presence of absence of transcription factors residing on inactive and active promoters. A candidate repressor protein, GCF2, identified through the work done in the previous application cycle will be examined for effects on transcription, histone acetylation, and DNA methylation. Overall, this proposal will define the mechanisms underlying repression of the TNF alpha locus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
USIDNET: A resource for clinical immunologists
-
批准号:10410606
-
项目类别:
-
资助金额:$134.93万
-
财政年份:2022
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
Non-coding RNA Regulation of TNF Alpha
-
批准号:7989625
-
项目类别:
-
资助金额:$25.11万
-
财政年份:2010
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
Non-coding RNA Regulation of TNF Alpha
-
批准号:8070422
-
项目类别:
-
资助金额:$20.73万
-
财政年份:2010
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
Epigenomics of SLE
-
批准号:8126220
-
项目类别:
-
资助金额:$36.77万
-
财政年份:2009
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
Epigenomics of SLE
-
批准号:8521081
-
项目类别:
-
资助金额:$34.92万
-
财政年份:2009
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
Epigenomics of SLE
-
批准号:8318805
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2009
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
Epigenomics of SLE
-
批准号:7934622
-
项目类别:
-
资助金额:$37.92万
-
财政年份:2009
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
Advancing Careers of Investigators in Primary Immune Disorders
-
批准号:10250421
-
项目类别:
-
资助金额:$1.14万
-
财政年份:2009
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
Advancing Careers of Investigators in Primary Immune Disorders
-
批准号:10018655
-
项目类别:
-
资助金额:$1.28万
-
财政年份:2009
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
Epigenomics of SLE
-
批准号:7725549
-
项目类别:
-
资助金额:$38.44万
-
财政年份:2009
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
Training of Clinical Investigators in Primary Immune Deficiencies
-
批准号:8326287
-
项目类别:
-
资助金额:$12.24万
-
财政年份:2009
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
Immune Complex Stimulation of TNFalpha
-
批准号:7031781
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2003
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
Immune Complex Stimulation of TNFalpha
-
批准号:7211370
-
项目类别:
-
资助金额:$30.05万
-
财政年份:2003
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
Immune Complex Stimulation of TNFalpha
-
批准号:6606254
-
项目类别:
-
资助金额:$33.7万
-
财政年份:2003
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
Immune Complex Stimulation of TNFalpha
-
批准号:6730496
-
项目类别:
-
资助金额:$31.89万
-
财政年份:2003
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
Immune Complex Stimulation of TNFalpha
-
批准号:6873752
-
项目类别:
-
资助金额:$31.82万
-
财政年份:2003
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
TNF Alpha In Inflammation
-
批准号:6878623
-
项目类别:
-
资助金额:$34.05万
-
财政年份:2000
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
ROLE OF TNF ALPHA IN SLE
-
批准号:6349877
-
项目类别:
-
资助金额:$34.67万
-
财政年份:2000
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
TNF Alpha In Inflammation
-
批准号:6778571
-
项目类别:
-
资助金额:$35.75万
-
财政年份:2000
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
ROLE OF TNF ALPHA IN SLE
-
批准号:6046135
-
项目类别:
-
资助金额:$31.04万
-
财政年份:2000
-
负责人:KATHLEEN E SULLIVAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于PTEN/Akt1/HIF-1alpha通路探讨六仁通便汤改善功能性便秘的机制
-
批准号:2025JJ81110
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:喻融
-
依托单位:
Vdelta2-T细胞外泌体疫苗携带IFN-gamma和TNF-alpha诱导抗原提呈细胞成熟并促进EBV肿瘤免疫应答的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王系伟
-
依托单位:
NOX4-PKC alpha 介导的铁死亡在帕金森病多
巴胺能神经元变性中的作用及机制
-
批准号:Y24H090030
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:田均
-
依托单位:
肾上腺素能受体alpha2A在胃袖损伤修复中的作用机制和应用研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:于腾波
-
依托单位:
针对二氧化碳加氢制线性alpha烯烃反应的铁基催化剂局域配位环境调控及作用机制研究
-
批准号:22308346
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:李洪良
-
依托单位:
氮-和alpha-碳-双取代聚类肽的可控合成及结构-性能关系探索
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:宣孙婷
-
依托单位:
Alpha-变形菌的胞质趋化系统(F9)功能机制与无细胞生物传感器合成研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:李玉倩
-
依托单位:
肝脏雌激素相关受体alpha调控乳酸代谢的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:管敏
-
依托单位:
Alpha-碳化钼催化逆水汽迁移反应机理的原位AP-XPS研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:徐尧
-
依托单位:
反应堆芯部燃烧等离子体alpha粒子输运及无碰撞加热机理的理论探索
-
批准号:12275236
-
项目类别:--
-
资助金额:56万元
-
批准年份:2022
-
负责人:仇志勇
-
依托单位: